|
RRM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.439900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.036620E-01 |
| Normal-vs-Stage2 |
9.379000E-01 |
| Normal-vs-Stage3 |
1.239810E-01 |
| Normal-vs-Stage4 |
9.420500E-02 |
| Stage1-vs-Stage2 |
1.802370E-01 |
| Stage1-vs-Stage3 |
8.116200E-01 |
| Stage1-vs-Stage4 |
5.292400E-01 |
| Stage2-vs-Stage3 |
1.808800E-01 |
| Stage2-vs-Stage4 |
1.185020E-01 |
| Stage3-vs-Stage4 |
6.979600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.094400E-02 |
| Normal-vs-AfricanAmerican |
7.177900E-02 |
| Normal-vs-Asian |
7.502100E-02 |
| Caucasian-vs-AfricanAmerican |
2.274800E-01 |
| Caucasian-vs-Asian |
5.921000E-01 |
| AfricanAmerican-vs-Asian |
4.735200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.476200E-01 |
| Normal-vs-Female |
5.932300E-02 |
| Male-vs-Female |
3.886200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.708200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.377200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.891200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.577800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.480800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.762200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.020400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.518800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.230600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.298000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.724400E-01 |
| Classical-VS-Follicular |
1.43399999985583E-07 |
| Classical-VS-Other |
5.347700E-02 |
| Classical-VS-Normal |
4.039800E-03 |
| Tall-VS-Follicular |
4.837200E-04 |
| Tall-VS-Other |
3.320200E-02 |
| Tall-VS-Normal |
7.657100E-03 |
| Follicular-VS-Other |
8.954600E-01 |
| Follicular-VS-Normal |
9.531800E-02 |
| Other-VS-Normal |
3.064800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.766400E-01 |
| Normal-vs-N1 |
9.155200E-01 |
| N0-vs-N1 |
6.771200E-01 |
|
|
